Sangamo Therapeutics Inc at Barclays Virtual Gene Editing & Gene Therapy Summit Transcript
Welcome, everyone. My name is Gena Wang. I'm SMid Cap biotech analyst at the Barclays. It's my great pleasure to introduce our next presenting company, Sangamo Therapeutics.
On the call with me, we have Sandy Macrae, President and Chief Executive Officer; Sung Lee, Chief Financial Officer; and Aaron Feingold, Head of Corporate Communications.
With that, I hand over to you, Sandy.
Thank you, Gena. And let me share my slide, share my screen. It's wonderful how we've all become our own tech in these days.
So Gena, thank you very much for having us. It's a real pleasure to be here. I'll just get rid of this. So I want to talk to you about Sangamo. And of course, during today's presentation, I'll be making forward-looking statements, so please refer to our releases filings with the SEC.
We're Sangamo Therapeutics. And for us, it's about translating our groundbreaking science into
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
